Skip to Content
Merck
  • Novel inhibitor against Malassezia globosa LIP1 (SMG1), a potential anti-dandruff target.

Novel inhibitor against Malassezia globosa LIP1 (SMG1), a potential anti-dandruff target.

Bioorganic & medicinal chemistry letters (2015-07-23)
Shaohua Guo, Wenkang Huang, Jian Zhang, Yonghua Wang
ABSTRACT

Compelling evidence have demonstrated the role of lipase activity in the pathogenicity of Malassezia globosa toward dandruff and seborrheic dermatitis (D/SD). As a representative secreted lipase from M. globosa CBS 7966, Malassezia globosa LIP1 (SMG1) is considered a potential anti-dandruff target. In this study, homology modeling, docking-based virtual screening and in vitro lipase-based assay were integrated to identify the first hit compound against SMG1, with an IC50 of 20 Ī¼M against synthetic lipase substrate, and of 0.19 Ī¼M when using natural lipase substrate. Evaluation of similar compounds, along with docking, offered information on the binding patterns of the hit compound. This work is expected to serve as a starting point for the rational design of more potent inhibitors against SMG1.

MATERIALS
Product Number
Brand
Product Description

Avanti
18:1-d7 MG, Avanti Researchā„¢ - A Croda Brand 791646C